Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Canadian Consortium for the Investigation of Cannabinoids (CCIC) is a federally incorporated non-profit organization dedicated to advancing the understanding of the role of cannabinoids in health and disease. Established by a group of clinical and basic scientists, the CCIC promotes evidence-based research and education regarding the therapeutic potential and risks of cannabis-based medicines. The organization serves as a central hub for Canadian researchers, healthcare professionals, and students, facilitating knowledge exchange through annual conferences, accredited continuing medical education programs, and research grants. By bridging the gap between scientific discovery and clinical practice, the CCIC aims to improve patient care and inform public policy related to medical cannabis. Their work focuses on synthesizing complex data into actionable insights for the medical community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canadian Consortium for the Investigation of Cannabinoids.